Jaguar Health (JAGX) news
Recent news
Jaguar introduces its new fully electric Type 01 model, aiming to appeal to younger American customers - A shift from its traditional image as a favorite of UK prime ministers.
Jaguar is set to unveil its Type 01 electric vehicle in New York on October 8, 2026, marking a pivotal moment in the brand’s strategic shift toward an ultra-premium electric market. Priced at £130,000, the vehicle is designed to compete with luxury EVs from rivals such as Aston Martin and Bentley.…
AInvest Wire · 7d agoJaguar moves away from pink branding as it unveils Type 01 EV - WSJ
Jaguar has unveiled the Type 01 electric vehicle (EV), marking a shift in branding strategy following the polarizing reception of its previous concept, the Type 00, which was offered in colors including Miami pink . The Type 01 represents the automaker’s continued transition toward an electric-only…
AInvest Wire · Oct 7, 2026Trading released/resumed: (JAGX) Reason not available
Jaguar Health, Inc. (JAGX) shares experienced notable volatility in recent trading sessions, with the stock surging and retreating multiple times amid a series of corporate actions and market reactions. On October 5, 2026, trading in JAGX resumed following an unspecified pause, though no official…
AInvest Wire · Oct 5, 2026Trading halted: (JAGX) Due to limit-up limit-down trading pause
Trading in Jaguar Health Inc. (JAGX) was temporarily halted on September 22, 2026, due to a limit-up limit-down volatility pause . The stock experienced an extraordinary intraday surge, closing with a 1,190% gain following the announcement that the FDA had waived the 2027 PDUFA fee for Mytesi and…
AInvest Wire · Oct 5, 2026Trading released/resumed: (JAGX) Reason not available
Trading in shares of Jaguar Health, Inc. (JAGX) was halted at one point and has since resumed, according to available reports. At this time, no official reason has been disclosed for the trading halt. Investors are advised to monitor official announcements from the company or relevant regulatory…
AInvest Wire · Sep 25, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.